pH gradient-liquid chromatography tandem mass spectrometric assay for determination of underivatized polyamines in cancer cells.

[1]  Kangning Liu,et al.  Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression , 2016, Clinical Cancer Research.

[2]  M. Hogarty,et al.  Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma. , 2015, Translational pediatrics.

[3]  Martin P. Keough,et al.  Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment , 2013, Cancer Immunology Research.

[4]  Merja R. Häkkinen,et al.  Polyamine analysis by LC-MS. , 2011, Methods in molecular biology.

[5]  A. Hirsh,et al.  Theory and applications of a novel ion exchange chromatographic technology using controlled pH gradients for separating proteins on anionic and cationic stationary phases. , 2008, Journal of chromatography. A.

[6]  F. Gosetti,et al.  A new hydrophilic interaction liquid chromatography tandem mass spectrometry method for the simultaneous determination of seven biogenic amines in cheese. , 2008, Journal of chromatography. A.

[7]  L. Alhonen,et al.  Analysis of underivatized polyamines by reversed phase liquid chromatography with electrospray tandem mass spectrometry. , 2007, Journal of pharmaceutical and biomedical analysis.

[8]  R. Lock,et al.  Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. , 2007, Blood.

[9]  Marcel Ottens,et al.  pH-gradient ion-exchange chromatography: an analytical tool for design and optimization of protein separations. , 2007, Journal of chromatography. A.

[10]  Armağan Önal,et al.  A review: Current analytical methods for the determination of biogenic amines in foods , 2007 .

[11]  Andres J Klein-Szanto,et al.  Combination therapy with 2‐difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma , 2006, International journal of cancer.

[12]  A. Gugliucci.  Polyamines as clinical laboratory tools. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[13]  J. Bansard,et al.  Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers , 2000, Breast Cancer Research and Treatment.

[14]  F. Meyskens,et al.  A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma , 2004, Investigational New Drugs.

[15]  N. Seiler,et al.  Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. , 2003, Current drug targets.

[16]  L. Bennett,et al.  High-performance liquid chromatographic determination of biogenic amines in poultry carcasses. , 2002, Journal of agricultural and food chemistry.

[17]  G. A. Qureshi,et al.  Polyamines as cancer markers: applicable separation methods. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[18]  Wallace.  The physiological role of the polyamines , 2000, European journal of clinical investigation.

[19]  S. Fischer,et al.  Signal enhancement for gradient reverse-phase high-performance liquid chromatography-electrospray ionization mass spectrometry analysis with trifluoroacetic and other strong acid modifiers by postcolumn addition of propionic acid and isopropanol , 1995, Journal of the American Society for Mass Spectrometry.

[20]  L. Marton,et al.  Polyamines as targets for therapeutic intervention. , 1995, Annual review of pharmacology and toxicology.

[21]  L. Marton,et al.  Phase I-II clinical trial with alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis. , 1987, European Journal of Cancer and Clinical Oncology.

[22]  A. Sjoerdsma,et al.  Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. , 1986, Cancer treatment reports.

[23]  D. Russell,et al.  Clinical relevance of polyamines. , 1983, Critical reviews in clinical laboratory sciences.

[24]  C. Tardif,et al.  Initial characterization of a HTC cell variant partially resistant to the anti-proliferative effect of ornithine decarboxylase inhibitors. , 1978, Experimental cell research.

[25]  B. Metcalf,et al.  Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs , 1978 .

[26]  C. Tardif,et al.  Analogues of ornithine as inhibitors of ornithine decarboxylase. New deductions concerning the topography of the enzyme's active site. , 1978, Journal of medicinal chemistry.

[27]  D. Russell.  Increased polyamine concentrations in the urine of human cancer patients. , 1971, Nature: New biology.

[28]  S. Snyder,et al.  Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. , 1968, Proceedings of the National Academy of Sciences of the United States of America.